Intravenous push versus intravenous piggyback beta-lactams for the empiric management of gram-negative bacteremia.
Kassandra MarshYanina DubrovskayaShin-Pung Polly JenNabeela AhmedArnold DecanoJustin SiegfriedJohn PapadopoulosCristian MerchanPublished in: Journal of clinical pharmacy and therapeutics (2020)
Our findings suggest no differences in clinical response with the use of IVP compared to IVPB FEP and MEM for treatment of GNB. This form of administration may be considered as a fluid conservation strategy in times of shortage.